The main focus of my research program is the quality of care received by patients with cancer especially in regards to delivery of systemic therapy. I am also interested in understanding the evolution and dissemination of findings from randomized controlled trials in cancer.
Palliat Med. 2019 Dec 18;:269216319876915
Sorensen A, Le LW, Swami N, Hannon B, Krzyzanowska MK, Wentlandt K, Rodin G, Zimmermann C
Curr Oncol. 2019 Oct;26(5):e624-e639
Powis M, Groome P, Biswanger N, Kendell C, Decker KM, Grunfeld E, McBride ML, Urquhart R, Winget M, Porter GA, Krzyzanowska MK
JAMA Netw Open. 2019 Oct 02;2(10):e1912823
Grant RC, Moineddin R, Yao Z, Powis M, Kukreti V, Krzyzanowska MK
BMC Cancer. 2019 Sep 05;19(1):884
Krzyzanowska MK, Julian JA, Powis M, Howell D, Earle CC, Enright KA, Mittmann N, Trudeau ME, Grunfeld E
Cancer Med. 2019 Aug 31;:
Karim S, Mackillop WJ, Brennan K, Peng Y, Siemens DR, Krzyzanowska MK, Booth CM
Cancer Med. 2019 Aug 12;:
Karim S, Booth CM, Brennan K, Peng Y, Siemens DR, Krzyzanowska MK, Mackillop WJ
Support Care Cancer. 2019 Jun 04;:
Sorensen A, Wentlandt K, Le LW, Swami N, Hannon B, Rodin G, Krzyzanowska MK, Zimmermann C
Ecancermedicalscience. 2019;13:ed88
Riechelmann RP, Krzyzanowska MK
CMAJ. 2019 Apr 23;191(16):E436-E445
Grewal K, Sutradhar R, Krzyzanowska MK, Redelmeier DA, Atzema CL
J Med Internet Res. 2019 Mar 28;21(3):e9958
Prince RM, Soung Yee A, Parente L, Enright KA, Grunfeld E, Powis M, Husain A, Gandhi S, Krzyzanowska MK



Medical Oncologist, Princess Margaret Cancer Centre
Associate Professor of Medicine, University of Toronto
Clinical Lead, Quality Care and Access, Systemic Treatment Program, Cancer Care Ontario
Adjuct Scientist, Institute for Clinical Evaluative Sciences